Eagle Health Investments LP Q1 2025 Filing

Filed May 12, 2025

Portfolio Value

$385.1B

Holdings

20

Report Date

Q1 2025

Filing Type

13F-HR

All Holdings (20 positions)

#StockSharesValue% PortfolioType
1
ARGXARGENX SE
74,990$44.4B11.53%
2
NTRANATERA INC
279,764$39.6B10.27%
3
ICLRICON PLC
209,190$36.6B9.51%
4
IM8NINSMED INC
443,300$33.8B8.78%
5
ILMNILLUMINA INC
343,361$27.2B7.07%
6
BMRNBIOMARIN PHARMACEUTICAL INC
382,612$27.0B7.02%
7
NBIXNEUROCRINE BIOSCIENCES INC
225,100$24.9B6.46%
8
DC4DEXCOM INC
356,921$24.4B6.33%
9
RAREULTRAGENYX PHARMACEUTICAL IN
627,600$22.7B5.90%
10
ALNYALNYLAM PHARMACEUTICALS INC
65,656$17.7B4.60%
11
PRCTPROCEPT BIOROBOTICS CORP
299,089$17.4B4.52%
12
EXASEXACT SCIENCES CORP
388,650$16.8B4.37%
13
INSPINSPIRE MED SYS INC
81,121$12.9B3.36%
14
AGIOAGIOS PHARMACEUTICALS INC
330,830$9.7B2.52%
15
AKROAKERO THERAPEUTICS INC
226,400$9.2B2.38%
16
ASNDASCENDIS PHARMA A/S
56,500$8.8B2.29%
17
TMDXTRANSMEDICS GROUP INC
100,661$6.8B1.76%
18
ISRGINTUITIVE SURGICAL INC
4,390$2.2B0.56%
19
VIRVIR BIOTECHNOLOGY INC
240,500$1.6B0.40%
20
IMCRIMMUNOCORE HLDGS PLC
46,300$1.4B0.36%